|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Accounts Receivable (net of allowances of $73,294 in 2020 and $76,293 in 2019) | ||||||||||||||||||||
| Lease Merchandise (net of accumulated depreciation and allowances of $878,259 in 2020 and $896,056 in 2019) | ||||||||||||||||||||
| Property, Plant and Equipment, Net | ||||||||||||||||||||
| Loans Receivable (net of allowances and unamortized fees of $37,649 in 2020 and $21,134 in 2019) | ||||||||||||||||||||
| Property, Plant and Equipment at Cost (net of accumulated depreciation of $317,704 in 2020 and $311,252 in 2019) | ||||||||||||||||||||
| Property, Plant and Equipment at Cost (net of accumulated depreciation of $326,340 in 2020 and $311,252 in 2019) | ||||||||||||||||||||
| Operating Lease Right-of-Use Assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other Intangibles (net of accumulated amortization of $164,324 in 2020 and $151,932 in 2019) | ||||||||||||||||||||
| Income Tax Receivable | ||||||||||||||||||||
| Prepaid Expenses and Other Assets | ||||||||||||||||||||
| Assets Held for Sale | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES & SHAREHOLDERS’ EQUITY: | ||||||||||||||||||||
| Accounts Payable and Accrued Expenses | ||||||||||||||||||||
| Accrued Regulatory Expense | ||||||||||||||||||||
| Deferred Income Taxes Payable | ||||||||||||||||||||
| Customer Deposits and Advance Payments | ||||||||||||||||||||
| Operating Lease Liabilities | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Commitments and Contingencies (Note 4) | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY: | ||||||||||||||||||||
| Common Stock, Par Value $0.50 Per Share: Authorized: 225,000,000 Shares at June 30, 2020 and December 31, 2019; Shares Issued: 90,752,123 at June 30, 2020 and December 31, 2019 | ||||||||||||||||||||
| Additional Paid-in Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Stockholders' Equity before Treasury Stock, Total | ||||||||||||||||||||
| Less: Treasury Shares at Cost | ||||||||||||||||||||
| Common Stock: 23,613,045 Shares at June 30, 2020 and 24,034,053 at December 31, 2019 | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities & Shareholders’ Equity |
Loading...
